Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 272 entries
View as:

Exploratory Study to Assess the Short Term Intratumoural and Peripheral Effects of BN83495 in Postmenopausal Women With Newly Diagnosed Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01230970 Org: User:
Start: 05/31/11 End: 05/31/11 Due: 05/31/12

Efficacy and Safety Study of Dysport® Used for Migraine Prophylaxis

Phase: N/A Priority: Normal
NCT ID: NCT00301665 Org: User:
Start: 02/28/03 End: 03/31/05 Due: 03/31/06

Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours

Phase: N/A Priority: Normal
NCT ID: NCT02853422 Org: User:
Start: 04/30/16 End: 01/31/17 Due: 01/31/18

Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With IGF-1 Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT00125190 Org: User:
Start: 07/31/05 End: 01/31/09 Due: 01/31/10

Perception of Cohesion Within a Relationship (Dyadic Adjustment) on the Quality of Life of Patients With Prostate Cancer With Gonadotropin-releasing Hormone.

Phase: N/A Priority: Normal
NCT ID: NCT02630641 Org: User:
Start: 10/31/15 End: 11/30/17 Due: 11/30/18

A Study to Observe Demography and the Outcome of Prostate Cancer Patients Treated With 6-month Triptorelin Formulation in Italy

Phase: N/A Priority: Normal
NCT ID: NCT05759273 Org: User:
Start: 04/24/23 End: 09/30/24 Due: 09/30/25

A Study to Collect the Somatuline® Injector Device Preferences of Patients Living With Neuroendocrine Tumor (NET) and Nurses Involved in the Care of Patients With NET

Phase: N/A Priority: Normal
NCT ID: NCT05922579 Org: User:
Start: 06/15/23 End: 12/01/23 Due: 12/01/24

A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers

Phase: N/A Priority: Normal
NCT ID: NCT01743469 Org: User:
Start: 12/31/12 End: 04/30/16 Due: 04/30/17

Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly

Phase: N/A Priority: Normal
NCT ID: NCT00234572 Org: User:
Start: 05/31/00 End: 01/03/03 Due: 01/03/04

Quality of Life in Patients With Inoperable Malignant Bowel Obstruction

Phase: N/A Priority: Normal
NCT ID: NCT02365584 Org: User:
Start: 01/31/15 End: 01/16/18 Due: 01/16/19

Efficacy, Safety and Tolerability of Eziclen in Adult Subjects Undergoing Colonoscopy

Phase: N/A Priority: Normal
NCT ID: NCT02321462 Org: User:
Start: 03/31/15 End: 12/31/15 Due: 12/31/16

To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03017313 Org: User:
Start: 07/13/17 End: 06/14/21 Due: 06/14/22

Study on the Effects of Botulinum Toxin Type A on Back Muscle in Chronic Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT00246155 Org: User:
Start: 01/31/05 End: 07/01/05 Due: 07/01/06

An International Cross-sectional Survey to Evaluate the Burden of Fibrodysplasia Ossificans Progressiva (FOP) on Patients and Their Families.

Phase: N/A Priority: Normal
NCT ID: NCT04665323 Org: User:
Start: 01/18/21 End: 04/30/21 Due: 04/30/22

Efficacy, Safety and Tolerability of Eziclen®/Izinova® Versus Klean-prep® on Bowel Cleansing in Adolescents Undergoing Colonoscopy

Phase: N/A Priority: Normal
NCT ID: NCT03008460 Org: User:
Start: 10/15/17 End: 06/29/20 Due: 06/29/21

A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis.

Phase: N/A Priority: Normal
NCT ID: NCT05627362 Org: User:
Start: 12/29/22 End: 08/28/26 Due: 08/28/27

A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis

Phase: N/A Priority: Normal
NCT ID: NCT06016842 Org: User:
Start: 08/31/23 End: 05/31/29 Due: 05/31/30

Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC

Phase: N/A Priority: Normal
NCT ID: NCT03699579 Org: User:
Start: 02/22/19 End: 06/23/19 Due: 06/23/20

Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel

Phase: N/A Priority: Normal
NCT ID: NCT00447499 Org: User:
Start: 04/30/07 End: 12/31/08 Due: 12/31/09

Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01357980 Org: User:
Start: 05/31/11 End: 03/31/13 Due: 03/31/14

Efficacy and Safety of Lanreotide Versus Placebo for Treatment of Patients With Digestive Fistulae

Phase: N/A Priority: Normal
NCT ID: NCT00729313 Org: User:
Start: 04/30/00 End: 04/30/05 Due: 04/30/06

A Study to Collect Pre-existing Data on the Administration of Cabozantinib in Participants With Advanced Renal Cell Carcinoma (aRCC) Who Initiated Cabozantinib in 2nd Line in a Real-life Clinical Setting in France.

Phase: N/A Priority: Normal
NCT ID: NCT05444933 Org: User:
Start: 09/16/22 End: 05/12/23 Due: 05/12/24

Somatuline Predictive Factors in Acromegaly and NET

Phase: N/A Priority: Normal
NCT ID: NCT01840449 Org: User:
Start: 06/30/12 End: 05/31/17 Due: 05/31/18

Lanreotide 120mg Effectiveness in Subjects With Pancreatic Neuroendocrine Tumours (PanNET) in Routine Clinical Practice.

Phase: N/A Priority: Normal
NCT ID: NCT03947762 Org: User:
Start: 07/03/19 End: 04/30/21 Due: 04/30/22

Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder

Phase: N/A Priority: Normal
NCT ID: NCT00578097 Org: User:
Start: 02/29/08 End: 12/31/09 Due: 12/31/10